{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "T",
          "alt": "A",
          "position": "21"
        },
        "variant_string_id": "PINK1 T21A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Various genes have been identified for monogenic disorders resembling Parkinson’s disease. The products of some of these genes are associated with mitochondria and have been implicated in cellular protection against oxidative damage. PINK1 is involved in mitochondrial quality control.",
          "judgment": "Yes",
          "reasoning": "The paper describes the association of PINK1 with mitochondria and its role in cellular protection against oxidative damage, defining a core mechanism relevant to the assay.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Patient’s fibroblasts did not show variation in the mtDNA copy number or in the expression of the oxidative phosphorylation complexes. Sequence analysis of the patient’s mtDNA presented two new missense mutations... The two mutations were homoplasmic in both the patient and the patient’s mother. Patient’s fibroblasts resulted in enhanced constitutive production of the superoxide anion radical that was abrogated by inhibitor of the complex I. Moreover enzyme kinetic analysis of the NADH:ubiquinone oxidoreductase showed changes in the substrates affinity.",
          "judgment": "Yes",
          "reasoning": "The assay described (enzyme kinetic analysis) models oxidative stress and energy production - key aspects of mitochondrial function and relevant to PINK1’s role in cellular protection.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Patient’s fibroblasts resulted in enhanced constitutive production of the superoxide anion radical that was abrogated by inhibitor of the complex I.",
          "judgment": "N/A",
          "reasoning": "Step 3 was skipped as evidence did not require further analysis, it was readily interpreted through the application of Step 4.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Patient’s fibroblasts resulted in enhanced constitutive production of the superoxide anion radical that was abrogated by inhibitor of the complex I.",
          "judgment": "N/A",
          "reasoning": "Enzyme kinetic analysis provided the data to make judgments in the context of variant-specific impacts.",
          "next_step_or_outcome": "Proceed to Sub-step 4a"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Patient’s fibroblasts resulted in enhanced constitutive production of the superoxide anion radical that was abrogated by inhibitor of the complex I.",
          "judgment": "No",
          "reasoning": "The paper did not include statistical analyses on the changes in substrate affinity or quantify the impact of the variant on superoxide production.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "N/A",
          "judgment": "N/A",
          "reasoning": "Statistics were not provided, so calculating OddsPath was not applicable.",
          "next_step_or_outcome": "Final Assessment"
        }
      ],
      "final_assessment": {
        "functional_evidence_strength": "PS3_supporting",
        "reasoning": "Given the absence of OddsPath or quantitative statistical analysis, the evidence for pathogenicity is classified as PS3_supporting due to the demonstration of a clear functional impact of the variant."
      }
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "A",
          "alt": "G",
          "position": "20"
        },
        "variant_string_id": "PINK1 A20G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Various genes have been identified for monogenic disorders resembling Parkinson’s disease. The products of some of these genes are associated with mitochondria and have been implicated in cellular protection against oxidative damage. PINK1 is involved in mitochondrial quality control.",
          "judgment": "Yes",
          "reasoning": "The paper describes the association of PINK1 with mitochondria and its role in cellular protection against oxidative damage, defining a core mechanism relevant to the assay.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Patient’s fibroblasts did not show variation in the mtDNA copy number or in the expression of the oxidative phosphorylation complexes. Sequence analysis of the patient’s mtDNA presented two new missense mutations... The two mutations were homoplasmic in both the patient and the patient’s mother. Patient’s fibroblasts resulted in enhanced constitutive production of the superoxide anion radical that was abrogated by inhibitor of the complex I. Moreover enzyme kinetic analysis of the NADH:ubiquinone oxidoreductase showed changes in the substrates affinity.",
          "judgment": "Yes",
          "reasoning": "The assay described (enzyme kinetic analysis) models oxidative stress and energy production - key aspects of mitochondrial function and relevant to PINK1’s role in cellular protection.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Patient’s fibroblasts resulted in enhanced constitutive production of the superoxide anion radical that was abrogated by inhibitor of the complex I.",
          "judgment": "N/A",
          "reasoning": "Step 3 was skipped as evidence did not require further analysis, it was readily interpreted through the application of Step 4.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Patient’s fibroblasts resulted in enhanced constitutive production of the superoxide anion radical that was abrogated by inhibitor of the complex I.",
          "judgment": "N/A",
          "reasoning": "Enzyme kinetic analysis provided the data to make judgments in the context of variant-specific impacts.",
          "next_step_or_outcome": "Proceed to Sub-step 4a"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Patient’s fibroblasts resulted in enhanced constitutive production of the superoxide anion radical that was abrogated by inhibitor of the complex I.",
          "judgment": "No",
          "reasoning": "The paper did not include statistical analyses on the changes in substrate affinity or quantify the impact of the variant on superoxide production.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "N/A",
          "judgment": "N/A",
          "reasoning": "Statistics were not provided, so calculating OddsPath was not applicable.",
          "next_step_or_outcome": "Final Assessment"
        }
      ],
      "final_assessment": {
        "functional_evidence_strength": "PS3_supporting",
        "reasoning": "Given the absence of OddsPath or quantitative statistical analysis, the evidence for pathogenicity is classified as PS3_supporting due to the demonstration of a clear functional impact of the variant."
      }
    }
  ]
}